1,129
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach

, , , , &
Pages 236-242 | Received 03 Aug 2017, Accepted 15 Aug 2018, Published online: 02 Oct 2018

References

  • Ludvigsson JF, Leffler DA, Bai J, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.
  • Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538–1544.
  • Choung RS, Larson SA, Khaleghi S, et al. Prevalence and morbidity of undiagnosed celiac disease from a community-based study. Gastroenterology. 2017;152:830–839 e5.
  • Berti I, Della Vedova R, Paduano R, et al. Coeliac disease in primary care: evaluation of a case-finding strategy. Dig Liver Dis. 2006;38:461–467.
  • Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–1228.
  • Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93.
  • Pinto-Sanchez MB, Bercik P, Verdu EF. Extraintestinal manifestations of celiac disease. Dig Dis. 2015;33:147–154.
  • Zanchetta MB, Longobardi V, Bai JC. Bone and celiac disease. Curr Osteoporos Rep. 2016;14:43–48.
  • Han Y, Chen W, Li P, et al. Association between coeliac disease and risk of any malignancy and gastrointestinal malignancy: a meta-analysis. Medicine (Baltimore). 2015;94:e1612.
  • Peterson M, Grossman S. Managing celiac disease for women: implications for the primary care provider. Gastroenterol Nurs. 2016;39:186–194.
  • Chou R, Bougatsos C, Blazina I, et al. Screening for celiac disease: evidence report and systematic review for the US Preventive Services Task Force. J Am Med Assoc. 2017;317:1258–1268.
  • Fuchs V, Kurppa K, Huhtala H, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014;49:1304–1310.
  • Vavricka SR, Vadasz N, Stotz M, et al. Celiac disease diagnosis still significantly delayed: Doctor’s but not patients’ delay responsive for the increased total delay in women. Dig Liver Dis. 2016;48:1148–1154.
  • Paez MA, Gramelspacher AM, Sinacore J, et al. Delay in diagnosis of celiac disease in patients without gastrointestinal complaints. Am J Med. 2017;130:1318–1323.
  • Rubio-Tapia A, Hill ID, Kelly CP, American College of Group. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676; quiz 77.
  • Richtlijn Coeliakie en Dermatitis Herpetiformis (Guideline Coeliac Disease and Dermatitis Herpetiformis). Nederlandse Vereniging Van Maag-, Darm-, en Leverziekten (Dutch Society of Gastroenterology); 2008.
  • Burger JP, Roovers EA, Drenth JP, et al. Rising incidence of celiac disease in the Netherlands; an analysis of temporal trends from 1995 to 2010. Scand J Gastroenterol. 2014;49:933–941.
  • Lucassen PLBJ, Albeda FW, Van Reisen MT, et al. NHG-Standaard Voedselovergevoeligheid (Eerste herziening) (Dutch primary care guideline food hypersensitivity). HUWE. 2010;53:537–553.
  • Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62:107–115.
  • West J, Logan RFA, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003;52:960–965.
  • Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol. 2009;9:49.
  • van Gils T, Rootsaert B, Bouma G, et al. Celiac disease in The Netherlands: demographic data of members of the Dutch Celiac Society. J Gastrointestin Liver Dis. 2016;25:441–445.
  • Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801.
  • Dickey W, McMillan SA. Increasing numbers at a specialist coeliac clinic: contribution of serological testing in primary care. Digest Liver Dis. 2005;37:928–933.
  • Shivaji UN, Ford AC. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality. Prim Health Care Res Dev. 2015;16:263–269.
  • Salinas M, Lopez-Garrigos M, Flores E, et al. Big differences in primary care celiac disease serological markers request in Spain. Biochem Med. 2017;27:231–236.
  • Lau MS, Sanders DS. Optimizing the diagnosis of celiac disease. Curr Opin Gastroenterol. 2017;33:173–180.
  • Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.
  • Sinclair D, Duncan H. What happens to patients with positive tissue transglutaminase and endomysium antibody results in general practice? J Clin Pathol. 2004;57:943–945.
  • Aziz I, Lewis NR, Hadjivassiliou M, et al. A UK study assessing the population prevalence of self-reported gluten sensitivity and referral characteristics to secondary care. Eur J Gastroenterol Hepatol. 2014;26:33–39.
  • van Gils T, Nijeboer P, IJssennagger CE, et al. Prevalence and characterization of self-reported gluten sensitivity in the Netherlands. Nutrients. 2016;8:714.
  • Catassi C, Elli L, Bonaz B, et al. Diagnosis of non-celiac gluten sensitivity (NCGS): the Salerno Experts’ Criteria. Nutrients 2015;7:4966–4977.
  • Kurppa K, Paavola A, Collin P, et al. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease. Gastroenterology. 2014;147:610–617.
  • Ukkola A, Kurppa K, Collin P, et al. Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study. BMC Gastroenterol. 2012;12:136.